DermiSense, Inc.
Biotechnology
DermiSense is working to disrupt the status quo by replacing expensive and resource-intensive blood sampling with an innovative low-cost, zero-power patch that extracts dermal interstitial fluid for local analysis or rapid lab tests. The company is providing a platform that integrates with new and existing sensor technology to analyze important biomarkers frequently.